「tokyo」の検索結果
13件：6～10件目を表示
-
compound (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President: Mr. Naoyuki Mochida; hereinafter: Mochida) as an eye drop treatment for Dry...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716.pdf -
compound (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President: Mr. Naoyuki Mochida; hereinafter: Mochida) as an eye drop treatment for Dry...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716_0.pdf -
ntagonist (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President: Mr. Naoyuki Mochida; hereinafter: Mochida) and licensed to Senju as an eye ...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf -
reinafter: Avarept® ), discovered and licensed from Mochida Pharmaceutical Co., Ltd. (Headquarters: Tokyo, Japan; President: Mr. Naoyuki Mochida; hereinafter: Mochida) and developed by Senju as an eye...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406.pdf -
2, hereinafter: Product), discovered and licensed by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President: Mr. Naoyuki Mochida; hereinafter: Mochida) and developed by Senju as an eye...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf